Latest stories on RHHBY
Market Update: NLY, BRO, SANM, SLB, RHHBY, BKR
Yahoo Top50 · neutralgeneral
Bernstein raises Roche stock price target on R&D outlook to CHF434.50
Investing.com Analyst Ratings61 · neutralanalyst
Roche Holding AG (RHHBY) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Roche launches FDA-cleared PCR test; expands women's health portfolio
Seeking Alpha59 · neutralproduct/pr
Roche jumps despite reiterated 2026 outlook
Seeking Alpha58 · neutralgeneral
Roche Holding AG 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Why is Roche stock climbing today?
Investing.com Markets50 · neutralgeneral
Roche stock rating reaffirmed at Buy by UBS on strong quarter
Investing.com Analyst Ratings61 · neutralanalyst
Roche blockbuster drugs drive growth as currency effects bite
Reuters67 · bullishearnings
Roche Holding Non-GAAP EPS of CHF 10.85, revenue of CHF 30.36B
Seeking Alpha47 · neutralearnings
Roche Quarterly Sales Held Back by Blockbuster Eye Drug
Bloomberg38 · neutralearnings
Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America | RHHBY Stock News
StockTitan55 · neutralproduct/pr
Teva, Polpharma ink licensing pact for biosimilar targeting Roche’s Ocrevus
Seeking Alpha63 · neutralm&a
Roche receives CE Mark for blood test to identify tuberculosis infection | RHHBY Stock News
StockTitan63 · neutralproduct/pr
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Morningstar73 · bullishproduct/pr